Skip to content
APRE Aprea Therapeutics, Inc. Common stock
$1.61 -0.63% -0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy APRE stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 9.3M
Enterprise value -6600925
Trailing PE 0.47928512
Forward PE -1.5588236
PEG Ratio -0.05559707392
Enterprise to EBITDA 0.447
Enterprise to revenue -7.849
Price to book MRQ 0.6818182
Price to sales TTM 11.013118

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-06-30
Revenue (TTM) 841.0K
EBITDA -14774702
Diluted EPS TTM -2.3
Total Cash (MRQ) 16.5M
Current ratio (MRQ) 5.344
Operating Cash Flow (TTM) -12741123

APRE trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent APRE News

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.